Novocure to Evaluate Tumor Treating Fields Therapy with VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, to Treat Pancreatic Cancer Through Clinical Trial Collabora…

Novocure (Nasdaq: NVCR) announced today that it has entered into a clinical trial collaboration and supply agreement with ...